MUMBAI, India, June 19 -- Intellectual Property India has published a patent application (202617054779 A) filed by Beijing Wisdomab Biotechnology Co. , Ltd.; Genrix Shanghai Biopharmaceutical Co. , Ltd.; and Chongqing Genrix Biopharmaceutical Co. , Ltd. on April 29, 2026, for Antibodies Binding To Hla-A02/Hbsag Complex And Use Thereof.
Inventors include Zhang, Xueping; Liu, Zhigang; Zhou, Xiaowei; Liu, Yulan; Hao, Xiaobo; Zhang, Suhua; and Hu, Junjie.
The application for the patent was published on June 05, 2026, under issue no. 23/2026.
Abstract: A bispecific antibody, comprising a first antigen-binding fragment that binds to an HLA-A02/HBsAg complex and a second antigen-binding fragment that binds to CD3; in the bispecific antibody, the antibody that binds to the HLA-A02/HBsAg complex is a single-domain antibody. A pharmaceutical composition comprising the bispecific antibody or the single-domain antibody and use thereof are also disclosed.
Disclaimer: Curated by HT Syndication.
